A predictive coding perspective on mismatch negativity impairment in schizophrenia
K Kirihara, M Tada, D Koshiyama, M Fujioka… - Frontiers in …, 2020 - frontiersin.org
Mismatch negativity (MMN) is a widely used biological marker for schizophrenia research.
Previous studies reported that MMN amplitude was reduced in schizophrenia and that …
Previous studies reported that MMN amplitude was reduced in schizophrenia and that …
Electroencephalography and event-related potential biomarkers in individuals at clinical high risk for psychosis
Clinical outcomes vary among youths at clinical high risk for psychosis (CHR-P), with
approximately 20% progressing to full-blown psychosis over 2 to 3 years and 30% achieving …
approximately 20% progressing to full-blown psychosis over 2 to 3 years and 30% achieving …
Mismatch negativity in response to auditory deviance and risk for future psychosis in youth at clinical high risk for psychosis
Importance Although clinical criteria for identifying youth at risk for psychosis have been
validated, they are not sufficiently accurate for predicting outcomes to inform major treatment …
validated, they are not sufficiently accurate for predicting outcomes to inform major treatment …
Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia
Mismatch negativity (MMN) deficits in schizophrenia (SCZ) have been studied extensively
since the early 1990s, with the vast majority of studies using simple auditory oddball task …
since the early 1990s, with the vast majority of studies using simple auditory oddball task …
Mismatch negativity predicts remission and neurocognitive function in individuals at ultra-high risk for psychosis
M Fujioka, K Kirihara, D Koshiyama, M Tada… - Frontiers in …, 2020 - frontiersin.org
Background In the early intervention in psychosis, ultra-high risk (UHR) criteria have been
used to identify individuals who are prone to develop psychosis. Although the transition rate …
used to identify individuals who are prone to develop psychosis. Although the transition rate …
Predicting remission in subjects at clinical high risk for psychosis using mismatch negativity
Background The declining transition rate to psychotic disorder and the increasing rate of
nonpsychotic poor outcomes among subjects at clinical high risk (CHR) for psychosis have …
nonpsychotic poor outcomes among subjects at clinical high risk (CHR) for psychosis have …
The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review
Nicotine use, which is mostly done through smoking tobacco, is among the most
burdensome comorbidities of schizophrenia. However, the ways in which nicotine affects the …
burdensome comorbidities of schizophrenia. However, the ways in which nicotine affects the …
Prediction of individual responses to electroconvulsive therapy in patients with schizophrenia: Machine learning analysis of resting-state electroencephalography
Background Electroconvulsive therapy (ECT) has strong efficacy in patients with treatment
refractory schizophrenia. However, access to ECT has been limited by high costs …
refractory schizophrenia. However, access to ECT has been limited by high costs …
Thalamocortical dysrhythmia in patients with schizophrenia spectrum disorder and individuals at clinical high risk for psychosis
Thalamocortical dysrhythmia (TCD) is a model characterized by abnormal resting-state
thalamic oscillatory patterns where the alpha rhythm is replaced by cross-frequency …
thalamic oscillatory patterns where the alpha rhythm is replaced by cross-frequency …
Forecasting prognostic trajectories with mismatch negativity in early psychosis
Background Prognostic heterogeneity in early psychosis patients yields significant
difficulties in determining the degree and duration of early intervention; this heterogeneity …
difficulties in determining the degree and duration of early intervention; this heterogeneity …